Anticancer Efficacy of KRASG12C Inhibitors Is Potentiated by PAK4 Inhibitor KPT9274 in Preclinical Models of <i>KRAS</i> G12C-Mutant Pancreatic and Lung Cancers
Husain Yar Khan(The Barbara Ann Karmanos Cancer Institute), Asfar S. Azmi(Wayne State University)
Cited by 12
Related Papers
Targeting the Nuclear Export Protein XPO1/CRM1 Reverses Epithelial to Mesenchymal Transition
|Scientific Reports|2015|36
Targeting Cellular Metabolism With CPI-613 Sensitizes Pancreatic Cancer Cells to Radiation Therapy
|Advances in Radiation Oncology|2022|20